TIAA CREF Investment Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
$987K Buy
38,396
+7,589
+25% +$195K ﹤0.01% 2323
2018
Q4
$709K Sell
30,807
-233
-0.8% -$5.36K ﹤0.01% 2425
2018
Q3
$996K Sell
31,040
-2,446
-7% -$78.5K ﹤0.01% 2420
2018
Q2
$948K Buy
33,486
+802
+2% +$22.7K ﹤0.01% 2514
2018
Q1
$1.16M Sell
32,684
-519
-2% -$18.4K ﹤0.01% 2362
2017
Q4
$1.29M Buy
33,203
+2,689
+9% +$104K ﹤0.01% 2343
2017
Q3
$775K Sell
30,514
-16,801
-36% -$427K ﹤0.01% 2639
2017
Q2
$1.29M Buy
47,315
+2,260
+5% +$61.7K ﹤0.01% 2421
2017
Q1
$1.49M Sell
45,055
-3,329
-7% -$110K ﹤0.01% 2308
2016
Q4
$1.15M Sell
48,384
-27,159
-36% -$647K ﹤0.01% 2452
2016
Q3
$2.77K Buy
75,543
+2,689
+4% +$99 ﹤0.01% 1996
2016
Q2
$1.63M Sell
72,854
-11,297
-13% -$252K ﹤0.01% 2248
2016
Q1
$1.75M Buy
84,151
+15,015
+22% +$312K ﹤0.01% 2157
2015
Q4
$2.1M Buy
69,136
+6,130
+10% +$186K ﹤0.01% 2115
2015
Q3
$1.56M Sell
63,006
-6,350
-9% -$157K ﹤0.01% 2298
2015
Q2
$2.23M Buy
69,356
+32,931
+90% +$1.06M ﹤0.01% 2236
2015
Q1
$1.3M Hold
36,425
﹤0.01% 2478
2014
Q4
$827K Sell
36,425
-1,903
-5% -$43.2K ﹤0.01% 2759
2014
Q3
$744K Sell
38,328
-1,055
-3% -$20.5K ﹤0.01% 2799
2014
Q2
$1.43M Buy
39,383
+926
+2% +$33.6K ﹤0.01% 2500
2014
Q1
$1.49M Sell
38,457
-1,084
-3% -$42.1K ﹤0.01% 2411
2013
Q4
$1.13M Sell
39,541
-1,960
-5% -$55.9K ﹤0.01% 2597
2013
Q3
$1.49M Sell
41,501
-9,226
-18% -$330K ﹤0.01% 2390
2013
Q2
$1.69M Buy
+50,727
New +$1.69M ﹤0.01% 2272